(Q37234751)

19 August 2017

1 reference

title

Insights into mechanisms behind arteriogenesis: what does the future hold? (English)

1 reference

19 August 2017

5

Imo E Hoefer

0 references

Marianne C. Verhaar

object named as

Marianne C Verhaar

4

0 references

author name string

Melany C van Oostrom

1

1 reference

19 August 2017

Olivia van Oostrom

2

1 reference

19 August 2017

Paul H A Quax

3

1 reference

19 August 2017

Imo E Hoefer

5

1 reference

19 August 2017

publication date

4 August 2008

1 reference

Journal of Leukocyte Biology

19 August 2017

published in

1 reference

19 August 2017

volume

84

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

1379-1391

1 reference

What makes vessels grow with exercise training?

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Vascular remodeling and altered protein expression during growth of coronary collateral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Arteriogenesis versus angiogenesis: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Flow-mediated endothelial mechanotransduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

G protein-coupled receptors sense fluid shear stress in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Ion channels and their functional role in vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

The endothelial surface of growing coronary collateral arteries. Intimal margination and diapedesis of monocytes. A combined SEM and TEM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Activated macrophages induce vascular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Bone marrow-derived cells do not incorporate into the adult growing vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Collateral vessel physiology and functional impact- experimental evidence of collateral behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells an

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Magnetic resonance angiography reveals therapeutic enlargement of collateral vessels induced by VEGF in a murine model of peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Current status of cardiovascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Angiogenesis: where do we stand now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Human FGF-1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Molecular mechanisms of blood vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

The role of transforming growth factor-beta in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-beta1 release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

The chemokine system in arteriogenesis and hind limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

CCR2-/- knockout mice revascularize normally in response to severe hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Progenitor cell therapy in patients with critical limb ischemia without surgical options

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Transplantation of monocytes: a novel strategy for in vivo augmentation of collateral vessel growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Delayed arteriogenesis in hypercholesterolemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Transcriptional Profiling in Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Natural Killer Cells and CD4 + T-Cells Modulate Collateral Artery Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

Hypercholesterolaemia impairs monocyte function in CAD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0508281

21 January 2018

Identifiers

DOI

10.1189/JLB.0508281

1 reference

19 August 2017

1 reference